Apella Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional World ex US Core Equity 2 ETF
DFAX
|
+$27M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$8.07M |
| 3 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$5.63M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$5.24M |
| 5 |
Vanguard Total Bond Market
BND
|
+$4.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GS ActiveBeta US Small Cap Equity ETF
GSSC
|
+$2.46M |
| 2 |
First Trust North American Energy Infrastructure Fund
EMLP
|
+$1.55M |
| 3 |
Invesco Active US Real Estate Fund
PSR
|
+$1.25M |
| 4 |
EMTL
State Street DoubleLine Emerging Markets Fixed Income ETF
EMTL
|
+$968K |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$738K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.21% |
| 2 | Healthcare | 1.62% |
| 3 | Consumer Discretionary | 1.04% |
| 4 | Financials | 0.82% |
| 5 | Industrials | 0.72% |
Similar funds
Apella Capital's Q3 2021 Portfolio in Review
As of Q3 2021, Apella Capital held 215 positions worth $696M, up 14% from $609M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Apella Capital deployed $93.7M of net new capital in Q3 2021, opening 11 new positions and adding to 86 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 1,020,867 shares worth $26.4M.
By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GS ActiveBeta US Small Cap Equity ETF, an estimated $2.46M trimmed.
- Apella Capital's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 1,020,867 shares worth $26.4M.
- Apella Capital added most to Vanguard Total International Bond ETF in Q3 2021, an estimated $8.07M increase.
- Apella Capital's biggest Q3 2021 reduction was GS ActiveBeta US Small Cap Equity ETF, cutting an estimated $2.46M.
- Apella Capital fully exited State Street SPDR S&P Biotech ETF in Q3 2021, selling an estimated $738K.
- Apella Capital's ten largest holdings make up 42% of its $696M portfolio in Q3 2021.
- Apella Capital opened 11 new positions and closed 16 in Q3 2021.
- Apella Capital's portfolio value rose 14% quarter-over-quarter to $696M.
Based on Apella Capital's 13F filing for Q3 2021, filed 12 Oct 2021.